Shiawassee Co. hospital to be first in state to administer new Alzheimer’s drug
A new Alzheimer’s therapy treatment is giving patients in the community hope.Five patients are set to undergo a new drug ...
Tampa Bay Times10d
New Alzheimer’s drug in demand but who should take it?
USF’s Memory Disorders Clinic fielding requests from patients and their families hoping that Donanemab ... the FDA, the drug is approved for people with early symptomatic Alzheimer’s disease ...
Forbes11d
A New Era For Alzheimer’s Disease May Be Around The Corner
The recent FDA approval ... while donanemab infusions are required monthly. Dr Howard Fillit, co-founder and chief science officer of the Alzheimer’s Drug Discovery Foundation (ADDF) described ...
Medical News Today7d
Alzheimer's: Are newly approved drugs making a real-life difference?
After a lull of nearly 2 decades, the Food and Drug Administration ... early-stage Alzheimer’s disease and lower baseline beta-amyloid levels. The FDA has granted lecanemab and donanemab ...
Seeking Alpha7d
Eli Lilly Alzheimer’s drug set to face same fate as Biogen’s in U.K.: report
Alzheimer's drug Leqembi for use in the country's national health service (NHS), The Telegraph reported Saturday that their Eli Lilly (NYSE:LLY) will face the same fate for its drug, donanemab ...
Daily Mail7d
Second 'wonder' drug for Alzheimer's hailed by scientists as the 'best ever' treatment for the disease set to be blocked for NHS use
A second Alzheimer’s drug is expected to be blocked for use by the NHS, it has been reported. Donanemab – hailed by scientists as the ‘best ever’ treatment for the disease – has been ...
STAT11d
Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome
A year ago, after much fanfare and controversy, the Food and Drug ... Alzheimer’s disease. But doctors have been hesitant to prescribe the drug and its pharmacological cousin, Eli Lilly’s ...
Reuters8d
Eli Lilly Alzheimer's drug to be blocked for use by NHS, The Telegraph reports
Aug 23 (Reuters) - Eli Lilly's (LLY.N), opens new tab treatment for early Alzheimer's is expected to be blocked ... Telegraph reported on Friday. The drug donanemab would be rejected by the ...
Medical News Today10d
Kisunla side effects: What you should know
Kisunla (donanemab-azbt) is a brand-name injection for IV infusion that’s prescribed for certain types of Alzheimer’s disease in ... the Food and Drug Administration (FDA).
The Daily Telegraph8d
Second Alzheimer’s drug expected to be blocked for NHS use
A second Alzheimer’s ... s drug, having set a precedent with lecanemab, even if the Medicines and Healthcare products Regulatory Agency (MHRA) approves it. The MHRA may not approve donanemab ...
UK drug regulator approves Alzheimer’s drug but government likely won’t pay for it
Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact ...